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Neonatology (2014), http://dx.doi.o
http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2014, TaiwanSubcutaneous fat necrosis of the newborn (SCFN) is a rare, self-limited disorder of the panni-
culus which appears in the first few weeks of life. SCFN generally follows an uncomplicated
course. However, there are important complications for which the patient must be regularly
monitored, including thrombocytopenia, hypoglycemia, hypertriglyceridemia, and most
importantly, hypercalcemia. We report five infants with SCFN. All children were born at term.
The onset of lesions was between 1 day and 20 days after birth. The back was the most
frequent location. Birth hypoxia was the most frequent risk factor. Complications included hy-
percalcemia, hypoglycemia, and metastatic calcifications (disseminated subcutaneous calcifi-
cations, nephrocalcinosis, and myocardial calcifications). This study provides the first case of
SCFN in the context of hypoxic encephalopathy and refractory septic shock that required
extracorporeal membrane oxygenation (ECMO).
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Subcutaneous fat necrosis of the newborn (SCFN) is a
transient panniculitis which is typically presented in neo-
nates within the first 6 weeks of life.1 It is characterized byio Prada, 1, 4B. CP: 33900
gmail.com (L.G. Lara).
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Pediatric Association. Published bindurated, erythematous nodules, and plaques over bony
prominences such as the back, arms, buttocks, thighs, and
cheeks.2 The prognosis is generally good and usually only
symptomatic treatment is required.3 However, there are
rare and serious complications for which the patient must
be regularly monitored, especially hypercalcemia.2 Meta-
static calcifications due to prolonged hypercalcemia have
been reported in isolated cases.4 Five of our patients were
monitored in order to evaluate the risk factors, clinical
aspects, and variable outcomes in relation to SCNF. Mostt Necrosis of the Newborn: Report of Five Cases, Pediatrics and
y Elsevier Taiwan LLC. All rights reserved.
Figure 1 Skin lesions caused by subcutaneous fat necrosis of
one of the infants: erythematous plaques and nodules on the
back.
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+ MODELreports focused on one neonate while there are only three
that included more than five cases. To the best of our
knowledge, only one previous case of a neonate with
myocardial calcifications has been reported in the
literature.5
2. Case reports
We retrospectively analyzed five infants with SCFN, three
boys and two girls, who were diagnosed in a tertiary pedi-
atric hospital from 1995 to 2013 (Table 1). All infants were
born at term (range 37e41 weeks). The mean age of the
mothers at the time of delivery was 30 years (range
25e33 years). One mother had gestational diabetes and the
others had uncomplicated pregnancies. Three neonates
were delivered by emergency cesarean section because of
fetal distress and one infant required forceps delivery. Four
out of five (80%) children had normal birth weight and only
one was macrosomic. Except for one case, most of the
neonates showed birth asphyxia in the context of sepsis,
anemia, esophageal atresia, and meningitis. The median
1e5 minutes Apgar score was 3.6e6.6. Therapeutic hypo-
thermia and extracorporeal membrane oxygenation (ECMO)
were required in one infant with hypoxic encephalopathy
due to refractory septic shock and cardiorespiratory arrest
(CRA). The skin lesions appeared a mean of 8 days (range
1e20 days) after delivery, as indurated, erythematousTable 1 Subcutaneous fat necrosis of the newborn: evaluation
Patient/
sex
Term
(wk)
Labor Maternal
age/
history
Birth
weight
(g)
Apgar
(1e5
min)
Perinatal co
1/male 39 ECS 32/No 3520 5e7 Birth asphy
esophageal
2/female 38 Vaginal 30/No 3200 8e9 None
3/female 41 Vaginal
(forceps)
29/No 3350 5e9 Asphyxia,
meconium
aspiration
4/male 40 ECS 33/No 3820 0e4e7 Distress fet
hypoxic
encephalop
therapeutic
hypothermi
sepsis, anem
sinus throm
CRA
5/male 37 ECS 25/
Diabetes
3770 0e4 Hypoglycem
sepsis, hype
cardiomyop
cerebral pa
meningitis,
hypocalcem
ARF Z acute renal failure; CRA Z cardiorespiratory arrest; D
ECS Z emergency cesarean section; L Z localized; N Z normal; NK
* Fewer than four nodules.
y Four or more nodules.
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lesions with fewer than four nodules while Patient 4 and
Patient 5 developed diffuse lesions. The most common lo-
cations were the back followed by the arms (Figure 1). The
diagnosis was made on the basis of clinical features and
confirmed by skin biopsy. Histopathologically, all cases
showed fat cell necrosis with a dense inflammatory infil-
trate composed of lymphocytes, histiocytes, andof risk factors, clinical manifestations, and complications.
urse Onset/
resolution
(d)
Site L or D/mm Complications
xia,
atresia
20/60 Back L*/12  16 None
1/90 Back L/8  8 None
2/90 Neck,
Back,
buttocks
groin
L/20  30 Asymptomatic
hypercalcemia
al,
athy,
a, ECMO,
ia, ARF,
bosis,
12/90 Back,
arms
Dy Symptomatic
hypercalcemia
(hypertension,
vomiting,
lethargy),
hypoglycemia
ia,
rtrophic
athy,
lsy,
ia, ARF
6/150 Arms,
legs
D Hypercalcemia,
nephrocalcinosis,
myocardial
calcification,
disseminated
subcutaneous
calcifications
Z diffuse; ECMO Z extracorporeal membrane oxygenation;
Z not known.
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by radially arranged needle-shaped clefts and, at a later
stage, areas of calcification were found within the fat.
According to our follow up, the skin lesions on all infants
resolved spontaneously within a mean of 3.2 months (range
2e5 months). Patients with localized SCFN did not develop
any complications except for Patient 3, who had asymp-
tomatic hypercalcemia 39 days after delivery (11.9 mg/dL),
but the rates normalized after 1 month (8.4 mg/dL). Patients
with diffuse lesions developed symptomatic hypercalcemia.
Patient 4 had vomiting and was agitated. Laboratory analysis
on postnatal Day 30 revealed a serum calcium level of
16 mg/dL, with a phosphorus level of 5.2 mg/dL. For treat-
ment, the patient received low calcium and vitamin D for-
mula, hyperhydration, intravenous methylprednisolone at a
dose of 2 mg/kg/day, and furosemide (4 mg/kg/day). Due to
a lack of response, we started treatment with oral etidro-
nate (10 mg/kg/day) for 7 days to normalize his serum cal-
cium level (8.8 mg/dL). The patient was discharged and
underwent periodic calcium checkups. Patient 5 was
referred from another hospital with the diagnosis of SCFN
and delivery complications as detailed in Table 1. Echocar-
diogram depicted echodense lesions in the septum and the
right ventricular free wall, which were diagnosed as calcifi-
cations. On the radiography, there were calcium deposits in
the soft tissues of extremities corresponding to previous
areas of SCFN (Figure 2). A renal ultrasound revealed renal
parenchyma calcifications on Patient 5, who was 15 years old
and receiving annual checks that showed the same findings,
without affecting myocardial or renal function.
3. Discussion
SCFN is a rare type of localized lobular panniculitis which is
usually found in fullepost-term infants.5 The pathogenesis of
SCFN remains unclear. It has been postulated that any
neonatal distress may interfere with normal blood supply to
the fat tissue, creating an environment of hypoxia and hy-
pothermia, which is believed to lead to inflammation andFigure 2 (A) Echocardiographic apical four chamber view of the
wall; (B) X-rays of both legs show calcifications in the soft tissue cor
newborn (SCFN).
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higher proportion of saturated fats (i.e., stearic and palmitic
acids), which have a higher melting point (64 C) making
them more likely to crystallize under colder conditions.2
Possible neonatal risk factors include perinatal asphyxia,
meconium aspiration, cord accidents, hypothermia, hypo-
glycemia, anemia, thrombocytosis, and lactic acidosis.
Maternal associations include preeclampsia, hypertension,
gestational diabetes, cocaine or cigarette exposure, cal-
cium blocker use during pregnancy, and familial dyslipide-
mia. Traumatic birth and contact with cold surfaces are the
local causes.4,6 In our patients, birth asphyxia was the most
commonly identified predisposing factor.
Additionally, early cases of SCFN were documented in
neonates who underwent whole-body cooling prior to being
placed on cardiopulmonary bypass and therapeutic moder-
ate hypothermia for newborns with hypoxic-ischemic en-
cephalopathy.7,8 Patient 5 highlights the fact that induced
whole-body cooling for hypoxic-ischemic encephalopathy
may play a role in the development of SCFN. He was also
connected to ECMO due to refractory septic shock and CRA.
These factors could precipitate SCFN by causing decreased
tissue perfusion with relative hypoxia and hypothermia.
SCFN generally follows an uncomplicated course with
spontaneous resolution over several weeks. However, there
are rare and serious complications for which the patient
must be regularly monitored including thrombocytopenia,
hypoglycemia, hypertriglyceridemia, and most importantly
hypercalcemia.2 Hypoglycemia and thrombocytopenia pre-
cede the development of SCFN in infants with perinatal
hypoxia, which might suggest that they are most likely
caused by hypoxia injury. In Patient 5, hypoglycemia was
found 10 days before skin lesions appeared and this could be
due to birth asphyxia. Hypercalcemia is not common, but it
is one of the most dangerous complications.9 Although hy-
percalcemia generally manifests with the onset of skin le-
sions, it has been reported to occur as late as 6 months
afterwards, which is why patients with SCFN warrant long
term follow up of their serum calcium levels.3 Untreatedheart: echodense lesions in septum and right ventricular free
responding to previous areas of subcutaneous fat necrosis of the
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acute, like cardiac arrest and renal failure, as well as chronic
problems, such as metastatic calcifications. Metastatic cal-
cifications have been reported to be rarely found in kidneys,
falx cerebri, skin, myocardium, liver, inferior vena cava, and
gastric mucosa.2,4,5,7 Patient 5 was admitted with extensive
metastatic calcifications. It was impossible to know the
severity or the duration of his hypercalcemia, because he
had been transferred from another hospital. The pathogen-
esis of hypercalcemia is not fully understood.10 The most
widely accepted theory proposes that the elevated 1,25-
Hydroxyvitamin D3 secreted from the granulomas of the skin
lesions can stimulate intestinal calcium uptake.2 A correla-
tion between the extension of SFCN and the presence of
truncal lesions with hypercalcemia was noted by Mahe´ et al.6
This correlation was also found in our patients.
The differential diagnoses including sclerema neo-
natorum, hemangioma, cellulitis, histiocytosis, erythema
nodosum, Faber disease, fibromatoses, and rhabdomyo-
sarcomas are all histologically different.11 Histopathologi-
cally, SCFN shows necrosis of the fat, abundant histiocytes,
multinucleated giant cells with granuloma formation, and
lipocytes with radially arranged needle-shaped clefts that
are doubly refractile under polarized light microscopy.2
In summary, a neonate who develops skin lesions
consistent with SCFN should be followed up for the possible
onset of hypoglycemia, thrombocytopenia, hyper-
triglyceridemia, and especially hypercalcemia. This study
provides the first case of SCFN in the context of a refractory
septic shock that required ECMO. It also represents variable
clinical courses ranging from localized lesions of SCFN to
diffused forms that developed symptomatic hypercalcemia
and metastatic calcifications.
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